General anaesthesia presents a profound mystery at the intersection of neuroscience, pharmacology, and the philosophy of mind. Despite over a century of clinical use, the mechanism by which anaesthetics induce loss of consciousness remains poorly understood. This is especially surprising given the chemical diversity of substances that act as general anaesthetics: they include everything from simple inert gases like xenon to larger, structurally complex molecules such as propofol or ketamine. All these compounds, despite their wide variation in structure and interaction profiles, have the capacity to completely suppress consciousness in a controlled and reversible way. Crucially, this suppression occurs without killing neurons or causing permanent damage, without shutting down the brain’s electrical activity or basic physiological functions, and typically without disrupting subconscious autonomic processes like breathing (in mild sedation) or heartbeat regulation.
What common feature of brain function is being targeted by such chemically disparate substances to produce such a specific and dramatic phenomenological effect? The fact that consciousness can be suppressed so cleanly and reliably, without any permanent damage, implies that consciousness is functionally delicate (sensitive to precise patterns or states of activity) but also biochemically robust (capable of returning unharmed once the anaesthetic wears off). This challenges assumptions in both neuroscience and cognitive science. Standard accounts typically invoke modulation of GABAergic inhibition, disruption of thalamocortical connectivity, or altered synaptic transmission, but none of these mechanisms fully explains the selectivity, reversibility, and universality of anaesthetic effects across such chemically varied agents.
General anaesthetics therefore offer us a tantalising clue about what consciousness might be, and how it might work, but not, it seems, a big enough clue to lead us to the solutions we're looking for. This reinforces the impression that as things stand, the correct answer is not currently on offer. Something similar applies to all the other problems I will be surveying in this chapter, starting with the singular nature of conscious experiences.
A 2PC-style approach to understanding general anaesthesia does not seek a specific pharmacological “switch” that turns consciousness off. Rather, it asks: what process must fail for consciousness to cease?
In 2PC terms, general anaesthetics prevent the brain from reaching the Embodiment Threshold. This reframes the empirical question: the blockade is not of awareness in general, sensory pathways, or cortical electrical rhythms. It is of the formation of the mesoscopic pattern of the self-model (the pattern that allows a system to become the referent of its own predictions and to hold valuations coherently across the specious present).
This reframing has practical implications. Instead of searching for a single molecular target shared across xenon, propofol, and ketamine, the focus shifts to what these substances disrupt at the mid-scale architecture of the brain. They interfere with the stability of the representational storm that would otherwise instantiate a coherent subject. Perception, memory, and reflexive processing remain largely intact, but the brain cannot organise itself into a unified, valuative self. Seen this way, anaesthetics do not reveal what matter produces consciousness; they reveal what a brain must do to support consciousness. They block the very process that LUCAS’s system once achieved: the self-referential integration of predictive templates across entangled alternatives.